Menu

Inotuzumab Ozogamicin - PF-05208773

Pfizer

Status

Treatments

Drug: Inotuzumab Ozogamicin

Study type

Expanded Access

Funder types

Industry

Identifiers

B193

Details and patient eligibility

About

Inotuzumab Ozogamicin Expanded Access Program

Sex

Volunteers

No Healthy Volunteers

Inclusion criteria

Exclusion criteria

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms

© Copyright 2026 Veeva Systems